Gregory Mark Weinhoff

Director at Arvelle Therapeutics GmbH

Gregory Mark Weinhoff

Gregory Mark Weinhoff

Director at Arvelle Therapeutics GmbH

Overview
Career Highlights

Axovant Sciences Ltd.
Axovant Sciences, Inc.
VaxInnate Corp.

RelSci Relationships

852

Number of Boards

11

Birthday

1971

Age

49

Number of Awards

1

Contact Data
Trying to get in touch with Gregory Mark Weinhoff? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Gregory Mark Weinhoff likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at SemperCare, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Arvelle Therapeutics GmbH

Relationship likelihood: Strong

Co-Founder at Collinson Howe Venture Partners, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer, Alucent Biomedical, Inc at Avera Health

Relationship likelihood: Strong

General Partner at HarbourVest Partners LLC

Relationship likelihood: Strong

Venture Partner at CHL Healthcare Partners

Relationship likelihood: Strong

Former President at Ella Health, Inc.

Relationship likelihood: Strong

Senior Vice President Commercial at Arvelle Therapeutics GmbH

Relationship likelihood: Strong

Relationship likelihood: Strong

Chairman of the Board, Chief Executive Officer, Co-Founder at American Renal Associates Holdings, Inc.

Relationship likelihood: Strong

Paths to Gregory Mark Weinhoff
Potential Connections via
Relationship Science
You
Gregory Mark Weinhoff
Director at Arvelle Therapeutics GmbH
Family Members
Parent
Comprehensive Ophthalmologist at Ophthalmic Consultants of Long Island

Ophthalmic Consultants of Long Island provides eye care services. It offers cataracts, glaucoma, cornea, retina, diabetic eye care, neuro-ophthalmology services. The company was founded in 1939 and is headquartered in Stony Brook, NY.

Education
MBA, Baker Scholar

Harvard Business School (HBS) is the graduate business school of Harvard University in Boston, Massachusetts, United States. The school offers a large full-time MBA program, doctoral programs, and many executive education programs. It owns Harvard Business School Publishing, which publishes business books, leadership articles, online management tools for corporate learning, case studies, and the monthly Harvard Business Review.

MD

Harvard Medical School (HMS) is the graduate medical school of Harvard University. It is located in the Longwood Medical Area of the Mission Hill neighborhood of Boston, Massachusetts.The school was founded by John Warren on September 19, 1782, with Benjamin Waterhouse, and Aaron Dexter.

AB in Economics

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

Career History
Partner
2001 - Current

CHL Medical Partners invests mainly in seed, start-up and early-stage companies in the healthcare sector. They focus on the biotechnology, pharmaceuticals, genomics, proteomics, drug delivery technology, diagnostic devices, medical and surgical instrumentation and healthcare services sectors.The firm looks for companies with experienced management teams that are developing innovative products or services for large, growing markets. Companies should also employ a business model that offers substantial long-term competitive advantages. CHL Medical Partners invests in companies located in the Continental US.Initial investments range from $250,000 to $6 million. The firm may invest up to $12 million over the life of an investment. CHL Medical Partners typically serves as the lead investor focusing on structuring the financing and building a long-term syndicate of co-investors. The firm typically takes a seat on their portfolio companies' boards of directors.

Partner
Current

CHL Medical Partners LP seeks investment opportunities in companies located in the US. The fund targets companies operating in the fields of biotechnology, pharmaceuticals, genomics, proteomics, drug delivery technologies, diagnostics, medical & surgical instrumentation and healthcare services. It provides financing for seed and early stage capital requirements with an initial investment size of $0.1 - $5 million per portfolio.

Venture Partner
Current

Healthinvest Equity Partners LP seeks investment opportunities in companies located in the US. The fund targets companies operating in the fields of healthcare services. The fund provides financing for seed, early, and later-stage capital requirements with an investment size of $100,000 - $2 million and invest up to $5 million in a single portfolio company over the life of an investment. It acts as a lead investor and also takes seat on the board.

Boards & Committees
Director
Prior

VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ.

Director
Prior

PrimeraDx, Inc. develops and commercializes molecular diagnostics systems. It offers ICEPlex System, an open platform that allows clinical researchers to design their assays for the development of multiplexed, multimodal, and quantitative in vitro diagnostic to simultaneously interrogate dozens of biomarkers in the same reaction. The company's ICEPlex System also enables to design complex multi-modal assays that test for disparate target types, such as SNPs, expression biomarkers, miRNAs, and fusion genes, as well as addresses research challenges in oncology, infectious diseases, translational medicine research, and pharma quality control. It also focuses on developing oncology products that are intended to support cancer research, diagnostics, and therapeutics; and companion diagnostics solutions that help pharmaceutical companies to design, develop, and validate custom CDx tests. The company was founded by Vladimir I. Slepnev in 2004 and is headquartered in Mansfield, MA.

Director
Prior

LuMend, Inc. used to develop medical devices. It delivered technology and services to interventional cardiologists, radiologists and vascular surgeons specializing in endovascular techniques for the treatment of peripheral vascular diseases. The company also provided a clinical solution to chronic total occlusions. LuMend was founded by John B. Simpson & Matthew R. Selmon in 1996 and was headquartered in Redwood City, CA.

Political Donations
$600
2007
Transactions
Details Hidden

HealthInvest Equity Partners LP raised money in a private placement transaction

Investments
Details Hidden

Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland.

Details Hidden

Ella Health, Inc. provides breast cancer screening and diagnostic services. Its 3D mammogram focuses on the breast cancer screening, prevention and early detection of diseases that predominantly target women. The company was founded by Joseph B. Hoban and Gregory Mark Weinhoff in 2011 and is headquartered in Lemoyne, PA.

Awards & Honors
Harvard Business School - George F. Baker Scholar
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Gregory Mark Weinhoff. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Gregory Mark Weinhoff's profile does not indicate a business or promotional relationship of any kind between RelSci and Gregory Mark Weinhoff.